Wednesday, 28 Jun 2017

You are here

RheumNow Week in Review – 12 August 2016

Highlights from this week on RheumNow.com include:

  1. ViDEO: Pearls on Methotrexate side effect management from Dr. Jack Cush at 2016 RNS meeting. Thanks to Healio! https://t.co/6zUJHRbbxF
  2. Great review of Raynauds Phenomenon in NEJM by Dr. Fred Wigley https://t.co/pzxpQlNQFH
  3. 10 Essential Facts about Seronegative #RA. It's the symptoms, not the labs that count most. 20% of RA is seronegative https://t.co/gEPqK3OXHT
  4. Walgreens establishes disposal “kiosk” for patients needing to discard old/dangerous/narcotic meds. . https://t.co/aDp5963Kq8 https://t.co/oigv282jZH
  5. In Japan, persistence on biologics highest in biologic-naïve (>95%) and older Pts & lowest w/ more comorbidities. https://t.co/4VTDOCpZeJ
  6. Should low-dose prednisone be used in Osteoarthritis? Conflicting data in RCTs https://t.co/7RhGFvGkD4 https://t.co/HKx7pi0K1s
  7. There are 3 kinds "hip pain" - 1 Buttock pain (70% from LS spine); 2. Side/trochanteric pain (20% from FM, Bursitis); 3. Anterior/groin (true hip Jt) (<10%)
  8. A single center 9 yr follow up study of 97 myositis saw 25% died, most from Infx(29%). Death increased w/ lung Dz (HR 1.8), infection (HR 4.2) https://t.co/c6Vp9BuN94
  9. There is No Added Lymphoma Risk with TNF Inhibitor Use
  10. Etanercept May Lower Alzheimers Risk in Rheumatoid Arthritis
  11. Cryptochromes Regulate Circadian Inflammation in RA
  12. 2016 EULAR Update to Gout Guidelines
  13. My Nurse Practitioner
Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

ACR Says Senate Healthcare Bill Falls Short of Protecting Americans with Rheumatic Disease

Dr. Sharad Lakhanpal, President of the American College of Rheumatology has responded to the Senate's proposed changes to healthcare coverage in the USA.

Highlights from EULAR 2017 - From RheumReports.com

Dr. Janet Pope reviews her favorite and least favorite presentations and abstracts from EULAR 2017. 

The RheumNow Week in Review – How to ACR/EULAR 23 June 2017

Dr. Jack Cush reviews his approach to attending and getting the most out of ACR or EULAR Congress meetings.

EULAR 2017 – Day 4 Highlights

Saturday was a day of big posters and special seminars at EULAR in Madrid.  In the morning, I passed on an interesting session on nailfold capillaroscopy led by Dr. M Cutolo and went to a JIA outcomes session. I reported on this in a video from day 4 (Saturday) called “Long-Term Comorbidities in JIA” – you can find it here.

Responder Criteria for Nonpharmalogical Treatment of Fibromyalgia.

Because of the subjective nature of fibromyalgia symptoms, tools for monitoring of disease activity and/or treatment assessment tools to evaluate effectiveness of nonpharmacological modalities are difficult to develop.